NASDAQ
Cosmo Pharmaceuticals N.V. (CMOPF) has a price/fcf ratio of -114.09x as of Tuesday, May 26, 2026. This represents a 230.13% decrease compared to its 12-month average of 87.67x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.